发明名称 4-Aza-17-substituted-5-alpha-androstan-3-one, their A and D homo analogs, process for their preparation and pharmaceutical compositions containing them.
摘要 <p>4-Aza-17-substituted-5 alpha -androstan-3-ones and their A- and D- homo analogs of the formula: &lt;CHEM&gt; where Formula (I) may also have the structure of partial Formulas (II) and or (III); wherein, A is (1) - CH2 - CH2 -; (2) - CH = CH -; &lt;CHEM&gt; or &lt;CHEM&gt; B is (1) &lt;CHEM&gt; where R&lt;1&gt; is, (a) hydrogen; (b) methyl or ethyl; (c) ethenyl; (d) ethynyl; (e) NR&lt;2&gt;R&lt;3&gt; where R&lt;2&gt; and R&lt;3&gt; are hydrogen or methyl; (f) cyano; or &lt;CHEM&gt; where X&lt;(-)&gt; is any anion and R&lt;4&gt; is , (a) OR&lt;5 &gt;where R&lt;5&gt; is C1-4 alkyl; or (b) NR&lt;6&gt;R&lt;7&gt;, where R&lt;6&gt; and R&lt;7&gt; are hydrogen or methyl; R min is hydrogen or methyl; R sec is hydrogen or beta -methyl; R''' is B-methyl or hydroxy; Z is (1) oxo ; (2) beta -hydrogen and alpha -hydroxy; or alpha -hydrogen or alpha -hydroxyl and (3) (Y)n Q where n = 0 or 1, Y is a straight or branched hydrocarbon chain of 1 to 12 carbon atoms and Q is (a) &lt;CHEM&gt; , where R&lt;8&gt; is, (i) hydrogen, (ii) hydroxyl, (iii) C1-4 alkyl (iv) NR&lt;9&gt; R&lt;1&gt;&lt;0&gt;, where R&lt;9&gt; and R&lt;1&gt;&lt;0&gt; are each independently selected from hydrogen, C1-4 straight or branched chain alkyl, C3-6 cycloalkyl, phenyl; or R&lt;9&gt;9 and R&lt;1&gt;&lt;0&gt; taken together with the nitrogen to which they are attached represent a 5-6 membered saturated ring comprising up to one other heteratom selected from oxygen and nitrogen. (v) OR&lt;1&gt;&lt;1&gt;, where R&lt;1&gt;&lt;1&gt; is M, where M is hydrogen or alkali metal, or C1-18 straight or branched chain alkyl; benzyl; or (b) OR&lt;1&gt;&lt;2&gt;, where R&lt;1&gt;&lt;2&gt; is, (i) C1-20 alkylcarbonyl , (ii) phenyl C1-6 alkylcarbonyl, (iii) C5-10 cycloalkylcarbonyl, (iv) benzoyl, or (v) C1-8 alkoxycarbonyl; (4) &lt;CHEM&gt; where the dashed bond replaced the 17 alpha hydrogen; (5) NH@-R&lt;1&gt;&lt;3&gt;, where R&lt;1&gt;&lt;3&gt;, is (a) C1-12 alkyl; or (b) NR&lt;9&gt;NR&lt;1&gt;&lt;0&gt;; (6) cyano; or (7) tetrazolyl; and pharmaceutically acceptable salts of the above compounds; active as testosterone 5 alpha -reductase inhibitors, and thus useful topically for treatment of acne, seborrhea, female hirsutism and male pattern baldness, and systemically in treatment of benign prostatic hypertrophy, breast carcinoma, and prostate carcinoma.</p>
申请公布号 EP0004949(A1) 申请公布日期 1979.10.31
申请号 EP19790101131 申请日期 1979.04.12
申请人 MERCK & CO. INC. 发明人 JOHNSTON, DAVID BRUCE RANDOLPH;REINHOLD, DONALD FLOYD;RASMUSSON, GARY HENRY;UTNE, TORLEIF;ARTH, GLEN EDWARD - DECEASED;JOBSON, RONALD BRADFORD
分类号 C07J33/00;C07J3/00;C07J11/00;C07J17/00;C07J41/00;C07J43/00;C07J73/00;(IPC1-7):07J73/00;61K31/55;61K31/435;07J71/00 主分类号 C07J33/00
代理机构 代理人
主权项
地址